Diseases, Conditions, Syndromes

Novel monoclonal antibody therapy for SARS-CoV-2

An entirely new approach to monoclonal antibody therapy shows that targeting the more genetically stable internal protein of the SARS-CoV-2 virus rather than the surface spike protein can also clear SARS-CoV-2, reports a ...

Diseases, Conditions, Syndromes

Coronavirus does not infect the brain but still inflicts damage

SARS-CoV-2, the virus that causes COVID-19, likely does not directly infect the brain but can still inflict significant neurological damage, according to a new study from neuropathologists, neurologists, and neuroradiologists ...

Oncology & Cancer

What are HeLa cells? A cancer biologist explains

In an amazing twist of fate, the aggressive cervical cancer tumor that killed Henrietta Lacks, a 31-year old African American mother, became an essential tool that helped the biomedical field flourish in the 20th century. ...

Diseases, Conditions, Syndromes

T cells fit to tackle Omicron, suggests new study

Research from the Hong Kong University of Science and Technology (HKUST) and the University of Melbourne has revealed that T cells, one of the body's key defenses against COVID-19, are expected to be effective in mounting ...

Oncology & Cancer

Researchers develop and test new anti-cancer vaccine

Researchers at Moffitt Cancer Center have developed and tested in mice a synthetic vaccine and found it effective in killing human papillomavirus-derived cancer, a virus linked to cervical cancers among others. The research ...

page 7 from 34